自体乳房重建的多学科诊疗:叙述性综述
本文综述乳腺癌自体乳房重建与放疗的多学科管理。随着显微外科进步,自体乳房重建适应证扩大;腋窝手术降级使乳房切除术后放疗指征增加,而放疗不再视为自体重建禁忌。精细放疗计划与患者选择有助减少并发症且不损肿瘤结局。
要点
- 腋窝手术降级使乳房切除术后放疗指征增加。
- 自体乳房重建不再是乳房切除术后放疗的禁忌。
- 精细放疗计划与患者选择有助减少并发症。
核心结论
- 多学科团队协作可在乳房切除术后放疗背景下保留乳房手术的美学成果而不损害疾病控制。
研究设计与样本
- 叙述性综述,检索范围未报告。
主要发现
- 显微外科进展使自体乳房重建不断发展,旨在减少供区并发症并改善美观。
- 腋窝手术降级使乳房切除术后放疗指征增加;观察显示自体重建背景下放疗并非禁忌。
- 不同手术技术可导致乳腺残留腺体组织数量和区域不同,患者选择重要以减少潜在残留病灶。
临床怎么用
- 通过多学科团队协作并全面理解各学科,可在乳房切除术后放疗背景下保留乳房手术成果且不损害疾病控制。
- 精细放疗计划可能减少并发症而不损害肿瘤结局。
- 手术技术改进美学效果时应优先保持肿瘤学指征。
局限性
- 本文为叙述性综述,未报告系统检索策略与纳入标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breast reconstruction and oncoplastic surgery have become an important part of breast cancer care. The use of autologous breast reconstruction (ABR) has evolved significantly with advances in microsurgery, aiming to reduce donor site complications and improve cosmesis. For years, immediate-ABR was considered a contraindication if postmastectomy irradiation (PMRT) was planned. As a result of de-escalation of axillary surgery the indication of PMRT are increasing along-side with observations that PMRT in the setting of ABR is not contraindicated. Surgical techniques may result in different amount and areas of breast residual glandular tissue and patient selection is important to reduce potential residual disease. Meticulus radiation planning is important to potentially reduce complications without compromising oncologic outcomes. Surgical techniques change constantly in aim to improve aesthetic results but should most importantly maintain priority to the oncological indications. By multidisciplinary team work with a comprehensive understanding of each discipline, we can preserve the accomplishments of breast surgery in the setting of PMRT, without compromising disease control.
引用
- Kaidar-Person O, Hermann N, Poortmans P, et al. A multidisciplinary approach for autologous breast reconstruction: A narrative (re)view for better management. Radiother Oncol. 2021. PMID: 33582192. doi:10.1016/j.radonc.2021.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。